SCHEMBL26422970

SCHEMBL26422970

C=C(Nc1cc(CC(C)C(C)C)ccc1C)C(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 10/20 0.40
ALOX12 P18054 6/20 0.40
MEN1 O00255 3/20 0.40
CYP3A4 P08684 3/20 0.40
KMT2A Q03164 3/20 0.40
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 2/20 0.40
ESR1 P03372 2/20 0.40
TP53 P04637 2/20 0.40
HPGD P15428 2/20 0.40
MAPK1 P28482 2/20 0.40
RECQL P46063 2/20 0.40
HIF1A Q16665 2/20 0.40
HSD17B10 Q99714 2/20 0.40
NR3C1 P04150 2/20 0.40
FOS P01100 2/20 0.40
TTR P02766 2/20 0.40
JUN P05412 2/20 0.40
HSD17B1 P14061 2/20 0.40
HSD17B2 P37059 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26080097 0.76 ALDH1A1 (0.47) MEN1KMT2AALDH1A1KDM4ETP53
SCHEMBL23717895 0.73 MEN1 (0.50) MEN1KMT2AALDH1A1TP53MAPK1
SCHEMBL26422946 0.71 SMN1; SMN2 (0.37) MEN1CYP3A4KMT2AALDH1A1RECQL
SCHEMBL21212233 0.69 NPC1 (0.53) ALOX12ALDH1A1KDM4EHPGDMAPK1
SCHEMBL26080323 0.68 ALDH1A1 (0.34) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL26968733 0.67 LMNA (0.48) ALOX15ALOX12MEN1CYP3A4KMT2A
SCHEMBL20428090 0.66 ALOX15 (0.38) ALOX15ALOX12MEN1CYP3A4KMT2A
SCHEMBL24324875 0.65 TRPA1 (0.41) ALOX15ALOX12MEN1CYP3A4KMT2A
SCHEMBL21185398 0.65 TSHR (0.34) MEN1KMT2AALDH1A1KDM4EMAPK1
SCHEMBL18930369 0.64 TRPA1 (0.43) ALOX12MEN1KMT2AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230128688-A1 DIRECTED CONJUGATION TECHNOLOGIES KLEO PHARMACEUTICALS, INC. 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230128688-A1 DIRECTED CONJUGATION TECHNOLOGIES CD2BP2, CD2, CD47 ALOX15 4304/4885ALOX12 4360/4885MEN1 2845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.